Patrik Jeanmonod is CFO at Cytek Biosciences, Inc. (CTKB). They have made 2 open-market trades across 1 company since 2022, most recently 2024-03-11.
CIK 0001873085
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTKB | 99,377 | $523K |
Shares reported on the most recent Form 4, priced at the 2024-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTKB | SELL · 10b5-1 | 2023-12-26 | 2023-12-27 | $9.50 | $29K | -10.3% | -10.0% | -33.2% |
| CTKB | SELL · 10b5-1 | 2023-11-24 | 2023-11-27 | $6.94 | $21K | +13.1% | +39.3% | +29.5% |
| CTKB | SELL · 10b5-1 | 2023-10-24 | 2023-10-25 | $4.68 | $14K | -4.2% | +53.6% | +92.5% |
| CTKB | SELL · 10b5-1 | 2023-09-25 | 2023-09-26 | $6.38 | $19K | -16.0% | -27.9% | +48.7% |
| CTKB | SELL · 10b5-1 | 2023-08-24 | 2023-08-28 | $7.69 | $23K | -7.5% | -16.8% | -8.5% |
| CTKB | SELL · 10b5-1 | 2023-07-24 | 2023-07-25 | $9.17 | $28K | -0.4% | -17.0% | -49.4% |
| CTKB | SELL · 10b5-1 | 2023-06-26 | 2023-06-27 | $7.96 | $24K | +12.3% | +12.8% | -18.5% |
| CTKB | SELL · 10b5-1 | 2023-05-24 | 2023-05-25 | $7.76 | $23K | +5.5% | +2.3% | +1.4% |
| CTKB | SELL · 10b5-1 | 2023-04-24 | 2023-04-25 | $10.24 | $31K | +14.3% | -24.2% | -11.8% |
| CTKB | SELL · 10b5-1 | 2023-03-24 | 2023-03-24 | $8.33 | $25K | +0.7% | +17.9% | -5.0% |
| CTKB | SELL · 10b5-1 | 2023-02-24 | 2023-02-28 | $11.05 | $33K | -15.1% | -17.0% | -25.9% |
| CTKB | SELL · 10b5-1 | 2023-01-24 | 2023-01-25 | $11.05 | $39K | +13.0% | -4.4% | -18.0% |
| CTKB | SELL · 10b5-1 | 2022-12-27 | 2022-12-29 | $9.77 | $34K | +5.9% | +15.0% | -13.1% |
| CTKB | SELL | 2022-11-25 | 2022-11-28 | $14.30 | $50K | -5.4% | -22.5% | -15.9% |
| CTKB | SELL | 2022-10-24 | 2022-10-25 | $15.16 | $53K | -4.6% | -8.0% | -29.5% |
| CTKB | SELL · 10b5-1 | 2022-09-26 | 2022-09-28 | $12.63 | $44K | -0.1% | +11.5% | -30.4% |
| CTKB | SELL · 10b5-1 | 2022-08-24 | 2022-08-25 | $13.45 | $47K | -3.4% | -7.4% | +5.8% |
| CTKB | SELL · 10b5-1 | 2022-08-01 | 2022-08-03 | $12.80 | $45K | +6.2% | -16.5% | +10.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.